AstraZeneca CEO to step down as Q1 profit plunges

Thu, 04/26/2012 - 05:41 EDT - Yahoo! Business News

YahooBizNews

U.K. drug maker AstraZeneca PLC announced Thursday that its chief executive David Brennan is to retire as the company reported at 44 percent drop in first-quarter net profit.

Original article
Login or register to post comments

AstraZeneca CEO to Step Down as Profit Plunges 44%
U.K. drug maker AstraZeneca announced Thursday that its chief executive David Brennan is to retire as the company reported at 44% percent drop in first-quarter profit.
AstraZeneca Pensions: CEO, Yes - Workers, No
Pharmalot submits: How is this for poor timing?
AstraZeneca CEO quits as drug sales tumble
LONDON (Reuters) - AstraZeneca Chief Executive David Brennan is to step down on June
AstraZeneca CEO to Exit
AstraZeneca Chief Executive David Brennan is leaving after the troubled drug maker missed its first-quarter earnings and sales forecasts and cut its full-year profit targets yet again.
AstraZeneca CEO Leaving as Profits Slide
AstraZeneca Chief Executive David Brennan is leaving after the troubled drug maker missed its first-quarter earnings and sales forecasts and cut its full-year profit targets yet again.
Novartis Q4 profit halves to $1.2B on charges (AP)
BlackBerry back to profit as it sells a million Z10 handsets
US Spending, MasterCard, Royal Dutch Shell and AstraZeneca in Our Highlights for Today 02/01/2013
The US consumer spending in December was slower, while incomes increased. MasterCard with higher than expected revenue in Q4. Royal Dutch Shell reported weaker results in the final quarter of 2012. AstraZeneca’s CEO with lower expectations on profit for 2013.
AstraZeneca cuts another 2,300 jobs in sales, administration
AstraZeneca's Shrinking Act Could Increase Its Appeal
By EP Vantage:From 7,300 new job cuts to a contracting cost base and lower revenue guidance, in many ways AstraZeneca (AZN) is the incredible shrinking company. With chief executive David Brennan ruling out transformative acquisitions, the company appears to believe less should be able to deliver more.

Main menu

Secondary menu

AstraZeneca CEO to step down as Q1 profit plunges

Related

Latest

User login

Our Blog

Markets Map

Follow Us

Secondary menu